secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2022-12-12T23:59:59+00:00
Accession:  0001213900-22-079142
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio extends shareholder rights plan to Dec 30, 2023 via Amendment No. 2
------------------------------------------------------------------------------

- Board adopted Amendment No. 2 to Rights Agreement on December 9, 2022.
- Expiration date of the poison pill extended from Dec 30, 2022 to Dec 30, 2023.
- Amendment entered with VStock Transfer, LLC as rights agent.
- Prior amendment (Dec 2021) had extended the plan to Dec 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390022079142/0001213900-22-079142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390022079142/ea169921-8k_inmunebio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-079142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer